InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-13.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Selecky Christobel, Director. Insider active across 1 company, notably ImmunityBio, Inc.. In total, 7 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €1.3m. History available since 16 January 2026. The latest transaction was filed on 1 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
35,064 shares@ US$2.980.0011% mcap4.4% of flowCommon StockSEC:0001849739-26-000014:0
124,414 shares@ US$2.990.0038% mcap15.8% of flowCommon StockSEC:0001849739-26-000014:1
159,478 shares@ US$9.02360.015% mcap61.2% of flowCommon StockSEC:0001849739-26-000014:2
25,000 shares@ US$2.980.0008% mcap16.5% of flowCommon StockSEC:0001849739-26-000004:0
25,000 shares@ US$2.9816.5% of flowCommon StockSEC:0001849739-26-000004
50,000 shares@ US$2.9833.5% of flowCommon StockSEC:0001849739-26-000002
50,000 shares@ US$2.980.0015% mcap33.5% of flowCommon StockSEC:0001849739-26-000002:0
7 of 7 declarations
About Selecky Christobel
Christobel Selecky serves as a Director at ImmunityBio, Inc. She contributes to strategic decision-making and oversight of the company's activities. Christobel brings valuable expertise in biotechnology and product development, contributing to the company's leadership. Her commitment to innovation is an asset to ImmunityBio.
